InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,922.66
(
1.01%
)
Post# of 203990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

smartmoney77

Send PM Follow Ignore
Followers 41
Posts 3868
Boards Moderated 0
Alias Born 08/11/2006

smartmoney77

Re: INVestorTrends480 post# 39236

Monday, 08/21/2006 11:14:42 AM

Monday, August 21, 2006 11:14:42 AM

Post# of 203990
Maybe this is why....
nice dd Posted by: INVestorTrends480
In reply to: None Date:7/24/2006 12:09:24 PM
Post #of 36359

XKEM = Best Co in OTC. Price vs Potential.

Billions in Sales potential. Buyout Potential. Licensing Potential. Each major MRK (Merck) drug does anywhere between $2 Billion and 5 Billlion in Sales.


No reason why Nicosan/Hemoxin cant eventually do .5 Billion and 1 Billion. Given the fact that Nicosan is the best drug to treat SCD and was 7 Years in Development and has the least side effects with great results from treatment in the past year.


My posts are my opinion, make your own decisions. And remember, all fear is an illusion.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up